肾动脉硬化与狼疮肾炎患者动脉粥样硬化性心血管疾病风险的关联
该研究纳入189例1994至2017年间诊断性肾活检的狼疮肾炎患者,通过复核25%活检的肾动脉硬化(r-ASCL)分级并结合原始报告,发现严重r-ASCL与动脉粥样硬化性心血管疾病(ASCVD)事件风险升高9倍相关。
要点
- 狼疮肾炎诊断性肾活检中严重肾动脉硬化与ASCVD事件风险升高9倍相关。
- 原始病理报告低估r-ASCL,复核后任何及中重度r-ASCL患病率分别升至39%和12%。
- 建议系统性报告肾活检r-ASCL以识别ASCVD高危狼疮肾炎患者。
核心结论
- 狼疮肾炎诊断性肾活检中的严重肾动脉硬化可预测ASCVD事件,需更大规模研究系统报告r-ASCL并验证其与ASCVD的关联。
研究设计与样本
- 回顾性队列研究,纳入1994至2017年间接受诊断性肾活检的189例狼疮肾炎患者,手动验证所有新发ASCVD事件,并对25%活检按Banff标准复核r-ASCL分级。
主要发现
- 189例患者中78%为女性、73%为白人,中位年龄25岁;随访11年期间发生22例新发ASCVD事件。
- 原始报告任何r-ASCL占31%、中重度占7%;结合系统复核后分别升至39%和12%。
- 采用原始报告与复核r-ASCL的复合分级,诊断性活检中严重r-ASCL与ASCVD事件风险升高9倍相关。
关键数值与推荐
- r-ASCL分级采用Banff标准。
- 严重r-ASCL与ASCVD事件风险升高9倍相关。
临床怎么用
- 狼疮肾炎患者诊断性肾活检应系统评估并报告肾动脉硬化分级,以辅助识别ASCVD高危个体并加强预防。
局限性
- 仅对25%的活检进行r-ASCL复核,样本量有限,需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lupus nephritis (LN) predicts a 9-fold higher atherosclerosis cardiovascular disease (ASCVD) risk, highlighting the urgent need to target ASCVD prevention. Studies in IgA nephropathy reported that severe renal arteriosclerosis (r-ASCL) in diagnostic biopsies strongly predicted ASCVD risk. We recently found that 50% of LN pathology reports overlooked r-ASCL reporting, which could explain prior negative LN ASCVD risk studies. The present study was undertaken to examine associations between a composite of reported and overread r-ASCL and ASCVD events in LN. METHODS: Data were abstracted from all LN patients who underwent diagnostic biopsy between 1994 and 2017, including demographic information, ASCVD risk factors, and pathology reports at the time of LN diagnosis. We manually validated all incident ASCVD events. We overread 25% of the biopsies to grade r-ASCL using the Banff criteria. We supplemented the overread r-ASCL grade, when available, to determine the composite of reported and overread r-ASCL grade. RESULTS: Among 189 incident LN patients, 78% were female, 73% White, and the median age was 25 years. Overall, 31% had any reported r-ASCL, and 7% had moderate-to-severe r-ASCL. After incorporating systematically re-examined r-ASCL grade, the prevalence of any and moderate-to-severe r-ASCL increased to 39% and 12%, respectively. We found 22 incident ASCVD events over 11 years of follow-up. Using a composite of reported and overread r-ASCL grade, we found that severe r-ASCL in diagnostic LN biopsies was associated with 9-fold higher odds of ASCVD. CONCLUSION: Severe r-ASCL can predict ASCVD in LN; therefore, larger studies are required to systematically report r-ASCL and examine ASCVD associations.
引用
- Garg S, Raval AN, Hansen KE, et al. Association of Renal Arteriosclerosis With Atherosclerotic Cardiovascular Disease Risk in Lupus Nephritis. Arthritis Care Res (Hoboken). 2022. PMID: 33421305. doi:10.1002/acr.24552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。